ReferIndia News Sudeep Pharma's Shares End With A 30.54% Premium Against The Issue Price Of ₹593

ReferIndia News

Mumbai’s Trusted Investment Experts

24+ years of financial planning, portfolio management & wealth growth.

Learn More
News Image

Sudeep Pharma's Shares End With A 30.54% Premium Against The Issue Price Of ₹593

Published on: Nov. 29, 2025, 10:10 a.m. | Source: Free Press Journal

Shares of Sudeep Pharma ended with a premium of 30.54 per cent against the issue price of Rs 593. Proceeds from the fresh issue to the tune of Rs 75.81 crore will be used for capital expenditure toward the procurement of machinery for its production line located at the Nandesari Facility 1, Gujarat, and for general corporate purposes.

Checkout more news
Ad Banner

Planning a trip to Singapore?

Let's make it a seamless journey, bhai — full of fun, food, and unforgettable vibes! 🌟✈️

Contact Now
ReferIndia News contact